Participants with type 1 diabetes in a 12-week clinical trial showed significant improvements in two important health measures. Their HbA1c decreased and the amount of time they spent in hypoglycemia was reduced. The artificial pancreas system consists of an insulin pump and continuous glucose monitor, surgically placed under a patient’s skin, and is designed to mimic normal glucose regulation. An algorithm housed in a Bluetooth-connected smartphone tells the pump how much insulin is needed based on patient activity and other variables. Read more